This firm-fixed-price delivery order, valued at $16,031.60, was awarded to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods, by the U.S. Department of Veterans Affairs (VA). The order is for the TYVASO 64 MCG KIT, a pulmonary arterial hypertension treatment, and was placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs.
United Therapeutics is a biotechnology company that specializes in developing and commercializing products to address the unmet medical needs of patients with chronic and life-threatening conditions. The company holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a $50 million Blanket Purchase Agreement (BPA) and a $198 million FSS contract, which allow the agency to efficiently procure United Therapeutics' specialized pharmaceutical products for distribution to VA medical facilities across the country. This delivery order is part of the company's ongoing partnership with the VA to supply critical medications to veterans nationwide.
Generated 7/26/24, 10:20 AM